Amarin Corp Plc (AMRN)

[jessellivermore]

"Can you post a link ( or write the heading ) for the Jelis secondary intervention group analysis.
I remember reading it but can't find it now."


First the numbers. JELIS was a Japanese prospective, randomised open-label, blinded endpoint evaluation involving 18,645 patients. Two thirds of the patients were women. All patients had elevated LDL-Cs and were on low dose statins. 3664 patients had a history of CVD and they form a subset which is called the secondary prevention group.

"Not sure you can say the Reduce It patients are at twice the risk as the Jelis SIG group , but would need to read the report again" . .

KIWI...The estimated risk for CVD events in the REDUCE-IT is 5% annual (check out any of HD's or MY posts)..The risk in the secondary intervention JELIS group was 2.3% annual for the statin only group and 1.9% for the statin plus EPA. This information is also provide in my post 31195. 2.3% is less than one half of the 5% risk estimated in REDUCE-IT.

You need to read these posts more carefully...None of this information is obscure..Just Google up "JELIS Study and there it is..

":>) JL